Comparison Chart DiaMedica Therapeutics Inc.
Stocks
DMAC
CA25253X2077
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.450 USD | +1.57% |
|
-1.07% | -18.97% |
| 08-11 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-10 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Bio Therapeutic Drugs | +1.57% | -1.07% | -18.97% | +12.96% | +50.00% | 342M |
-
|
-
|
-
|
- Stock Market
- Stocks
- DMAC Stock
- Charts DiaMedica Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
